He has expertise in minimally invasive surgeries, including robotic surgery. Dr. Hamilton sees patients at all different stages of prostate cancer from those at risk to this with early diagnoses to advanced disease. His research interests in prostate cancer include the study of statins and metformin in prostate cancer prevention; whether genetic markers can be used to predict who will benefit from chemoprevention; and biomarkers of prostate cancer aggressiveness.